-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.P1.67 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I

Symposia: Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Michal Krawczyk1*, Lina Zelinger, PhD2*, Cynthie Wong, PhD2*, Hyunjun Nam, PhD.3*, Brad Thomas, PhD.4*, Nathan D Montgomery, MD, PhD2, Derek D Lyle, MD2* and Fernando Lopez-Diaz, PhD3*

1Neogenomics inc, Aliso Viejo, CA
2NeoGenomics, Fort Myers, FL
3Neogenomics inc, San Diego, CA
4Neogenomics inc., Houston, TX

Denis Ohlstrom, MSc1,2*, Hope Mumme, BSc3, Sean C Jordan, BS3*, Swati Bhasin, PhD4,5 and Manoj Bhasin, PhD3,4,5,6

1Emory University Medical School, Atlanta, GA
2Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA
3Department of Biomedical Informatics, Emory University, Atlanta, GA
4Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
5Department of Pediatrics, Emory University, Atlanta, GA
6Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA

Nam Nguyen, MS, PharmD1, Phani Krishna Parcha, PhD2*, Abderrahmane Tagmount, PhD3*, Bailey Gregory4*, Jeffrey E. Rubnitz, MD, PhD5, Raul C. Ribeiro, MD5, Xueyuan Cao, PhD6*, Todd A. Alonzo, PhD7*, Richard Aplenc, MD, PhD8, Alan S Gamis, MD, MPH9, Todd Cooper, DO10, E. Anders Kolb, MD11, Soheil Meshinchi, MD, PhD12, Stanley Pounds, PhD13*, Christopher Vulpe, MD, PhD14* and Jatinder K. Lamba, PhD15

1Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL
2Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL
3University of Florida, Gainesville, FL
4University of Florida College of Pharmacy, Gainesville
5Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
6Department of Health Promotion and Disease Prevention, University of Tennessee Health Science Center, Memphis, TN
7Univ. of Southern California Keck School of Med., Monrovia, CA
8Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
9Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO
10Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
11Leukemia & Lymphoma Society, Bronx, NY
12Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA
13Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
14University of Florida College of Veterinary Medicine, Gainesville, FL
15Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL

Jesse M. Tettero, MD1,2*, Maaike Heidinga2,3*, Tim R. Mocking1,2*, Glenn Fransen2,3*, Ezra S Beerman2,3*, Angèle Kelder1,2*, Willemijn Scholten1,2*, Alexander N. Snel1,2*, Lok Lam Ngai, MD1,2*, Costa Bachas, PhD1,2*, Arjan A. Van de Loosdrecht, MD, PhD3, Gert Ossenkoppele, MD, PhD3, David C. de Leeuw, MD, PhD3*, Jeroen J.W.M. Janssen, MD, PhD4 and Jacqueline Cloos, MD1,2*

1Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Department of Hematology, Amsterdam UMC, location Vrije Universiteit, Amsterdam, Netherlands
4Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands

Anders Östlund1*, Anna Staffas, PhD2*, Ulrika Norén-Nyström, MD, PhD3*, Henrik Hasle4, Linda Fogelstrand, MD, PhD5,6, Jonas Abrahamsson7* and Lars Palmqvist, MD, Professor8,9

1Institute of Biomedicine, Department of Laboratory Medicine, University of Gothenburg, GÖTEBORG, Västra Götaland, Sweden
2Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden
3Department of Clinical Sciences, Pediatrics, Umeå University Hospital, Umeå, Sweden
4Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
5Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
6Department of Clinical Chemistry, Sahlgrenska University, Gothenburg, Sweden
7Institute of Clinical Sciences, Department of Pediatrics, Queen Silvias Childrens Hospital, Gothenburg, Sweden
8Institute of Biomedicine, Department of Laboratory Medicine, University of Gothenburg, Gothenburg, Sweden
9Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden

Xinqi Li, M.D1*, Xiaoyan Liu, Ph.D1*, Jinxian Wu, Ph.D1*, Nan Zhang, Ph.D1* and Fuling Zhou, PhD2

1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China
2Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

Masayuki Umeda, MD, PhD1, Nicole Michmerhuizen, PhD2, Ryan Hiltenbrand2*, Juan Barajas, PhD2, Bright Arthur2*, Michael P Walsh, PhD2*, Guangchun Song1*, Jing Ma, PhD1*, Tamara Westover3*, Cristina Mecucci4, Danika Di Giacomo, PhD5*, Franco Locatelli, MD, PhD6, Riccardo Masetti, MD, PhD7*, Salvatore Bertuccio8*, Martina Pigazzi, PhD9*, Ilaria Iacobucci, PhD1, Charles G. Mullighan, MBBS, MD1 and Jeffery M. Klco, MD, PhD2

1Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
2St. Jude Children's Research Hospital, Memphis, TN
3St. Jude Children's Research Hospital, Memphis
4University of Perugia, Perugia, PG, ITA
5University of Perugia, Perugia, Italy
6Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Bambino Gesù Children's Hospital, Catholic University of the Sacred Heart, Roma, Italy
7Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
8IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
9Department of Women's and Children's Health, Onco-hematology lab and clinic, University of Padova, Padova, Italy

Talha Badar, MD1, Keith Knutson2*, James M. Foran, MD3, Naseema Gangat, MBBS4, Kevin Pavelko, Ph.D.5*, Scott H. Kaufmann, MD, PhD5, Mark R. Litzow, MD4, Hemant S. Murthy, MD6, Davitte Cogen2*, Margaret Ushman2*, Arini Arsana7*, Aref Al-Kali, MD4, Hassan Alkhateeb, MD4*, Ayalew Tefferi, MD4, Mrinal M. Patnaik, MD, MBBS8 and Mithun V Shah, MD, PhD4

1Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
2Mayo Clinic, Jacksonville, FL
3Hematology/Oncology, Mayo Clinic, Jacksonville, FL
4Division of Hematology, Mayo Clinic, Rochester, MN
5Mayo Clinic, Rochester, MN
6Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
7Mayo Clinic, Rochester
8Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

Elisabeth P Nacheva, MD, PhD1, Temenuzhka Boneva, MD PhD2*, Jenny O'Nions, MBBCh, PhD, MRCP, FRCPath3,4*, Andrew J. Wilson, PhD, BSc, MBBS, MRCP, MSc5*, Ke Xu6,7, Robert Baker8* and Rajeev Gupta9*

1University College London Medical School, Royal Free Campus, London, Eng, United Kingdom
2HSL Analytics LLP Oncogenomics, London UK and UCL Cancer Institute, London, GBR
3University College London NHS Foundation Trust, London, United Kingdom
4Department of Hematology, University College London NHS Foundation Trust, London, United Kingdom
5Department of Haematology, University College Hospital, University College of London Hospitals NHS Foundation Trust, London, United Kingdom
6Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
7University College London Hospitals NHS Foundation Trust, London, GBR
8Health Service Laboratories, UCLH, London, United Kingdom
9UCL Cancer Institute, London, GBR

Hyunjun Kang, PhD1*, Dinh Hoa Hoang2*, Melissa Valerio3*, Khyatiben V. Pathak4,5*, Lianjun Zhang, PhD6*, Ralf Buettner, PhD7*, Fang Chen6*, Katrina Estrella6*, William Graff8*, Ya-Huei Kuo, PhD2, Bin Zhang2*, Patrick Pirrotte4,5*, Le Xuan Truong Nguyen, PhD9* and Guido Marcucci, MD10

1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte
2Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
3Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research,Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
4Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ
5Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, CA
6Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
7Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
8Ostentus Therapeutics, Inc., Newport Coast, California, Newport Beach
9Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, South El Monte, CA
10Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA

Xue Chen, MD1*, Lili Yuan, MD1*, Yang Zhang, MD1,2*, Fang Wang, MD1*, Xiaoli Ma, MD1*, Jiancheng Fang, MD1*, Panxiang Cao, MS1,2*, Yijun Liu, MD1*, Zhixiu Liu, MD1*, Ming Liu1*, Jiaqi Chen, PhD1,2*, Xiaosu Zhou, PhD3*, Mingyue Liu1*, David Jin, MD2*, Peihua Lu, MD4,5* and Hongxing Liu, MD1,2,6,7

1Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China
3Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, AL, China
4Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China
5Beijing Lu Daopei Institute of Hematology, Langfang, China
6Department of Oncology, Capital Medical University, Beijing, China
7Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China

Paola Minetto, MD1, Fabio Guolo, MD, PhD1,2*, Sara Rosellini3*, Alfonso Piciocchi4*, Giovanni Marconi, MD5, Ernesta Audisio, MD6*, Giorgio Priolo7*, Cristina Papayannidis, MD8, Maurizio Martelli9*, Francesca Paola Paoloni4*, Monica Bocchia, MD10*, Francesco Lanza, MD11*, Albana Lico, MD12*, Fabio Ciceri13,14*, Matteo Giovanni Della Porta, MD15,16*, Marco Frigeni, MD17*, Luisa Giaccone, MD, PhD18*, Germana Beltrami, MD19*, Erika Borlenghi, MD20*, Maria Chiara Di Chio21*, Carmine Selleri, MD22, Enrico Crea, PharmD4*, Irene Urbino23*, Chiara Sartor, MD24*, Clara Minotti25*, Valentina Arena4*, Jacopo Nanni, MD24*, Giorgia Simonetti, PhD26*, Maria Teresa Bochicchio26*, Giuseppe Saglio, MD27, Adriano Venditti, MD28,29, Marco Vignetti, MD4*, Paola Fazi, MD30*, Elisabetta Tedone1*, Giovanni Martinelli, MD31,32 and Roberto M. Lemoli, MD1,2*

1IRCCS Ospedale Policlinico San Martino, Genoa, Italy
2Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
3Servizio di Citofluorimetria, Dipartimento di Anatomia Patologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
4GIMEMA Foundation, Rome, Italy
5Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Meldola, Italy
6SC Ematologia 2, AOU Città della Salute e della Scienza, Turin, Italy
7Haematology 2 - A.O.U San Giovanni Battista, Turin, ITA
8Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy
9Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
10UOC Ematologia, Azienda ospedaliero-universitaria Senese, Siena, Italy
11Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Italy
12Hematology Unit, San Bortolo Hospital, Vicenza, Italy, Vicenza, Italy
13Unit of Hematology and Bone Marrow Transplantation, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
14Vita-Salute San Raffaele University, Milan, Italy
15Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
16Department of Biomedical Sciences, Humanitas University, Milan, Italy
17Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
18Univesity of Torino, AOU Città Della Salute E Della Scienza Di Torino,, Torino, ITA
19U.O. Ematologia e terapie cellulari, IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy
20UO EMATOLOGIA, ASST Spedali Civili di Brescia, Brescia, ITA
21Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
22Department of Medicine and Surgery, Hematology, University Hospital San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy
2321. Department of Oncology and Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
24Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy
25Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ITA
26IRCSS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l, Meldola, Italy
27Dept. of Clinical and Biological Sciences, University of Turin, Turin, Italy
28Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
29Department of Onco-Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy, Italy
30GIMEMA Foundation, Data Center and Health Outcomes Research Unit, Rome, Italy
31Associate Professor Alma Mater Studiorum, University of Bologna, Institute of Hematology "L. and A. Seràgnoli,”, Bologna, Italy
32IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- IRST S.r.l., Meldola, Italy

Xingcheng Yang1*, Juan Peng, MS2*, Chunrui Li1, Yicheng Zhang1,3,4*, Xia Mao1*, Jue Wang, MD1* and Jia Wei1,5,6*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, AL, China
3Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China
4Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, China
5Department of Hematology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China
6Sino-German Joint Oncological Research Laboratory, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China

Zhiyao Ren, MD1,2,3*, Jolien Vanhooren1,2,3*, Charlotte Derpoorter1,2,3*, Barbara De Moerloose2,3,4* and Tim Lammens, PhD, MSc2,3,5*

1Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
2Cancer Research Institute Ghent (CRIG), Ghent, Belgium
3Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium
4Ghent University Hospital, Ghent, Belgium
5Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Oost-Vlaanderen, Belgium

Krish Shah1*, Jing Ma, PhD2*, Mohamed Djekidel, PhD1*, Guangchun Song2*, Masayuki Umeda, MD, PhD2, Yiping Fan, PhD1*, Gang Wu, PhD1* and Jeffery Klco, MD, PhD2

1St. Jude Children's Research Hospital, Memphis, TN
2Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN

Carmen Gonzalez, MS1*, Catia Simoes1*, Beñat Ariceta1*, David Martinez-Cuadron, PhD2*, Juan Miguel Bergua Burgues3*, Susana Vives4*, Lorenzo Algarra5*, Mar Tormo, M.D.6, Pilar Martinez Sanchez, M.D.7*, Josefina Serrano, MD8*, Pilar Herrera9*, Fernando Ramos, MD, MPH, PhD10*, Olga Salamero, MD11*, Esperanza Lavilla12*, Cristina Gil, MD13*, Jose Luiz Lopez Lorenzo14*, Maria Vidriales Vicente15*, Carmen Chillon15*, Jorge Labrador16*, Jose Francisco Falantes17*, Maria Jose Sayas Lloris18*, Rosa Ayala, MD, PhD19*, Joaquin Martinez-Lopez, MD, PhD19*, Sara Villar20*, Maria Jose Calasanz, PhD1,21*, Felipe Prosper, MD, PhD1, Jesus San Miguel1*, Miguel A. Sanz, MD, PhD2, Pau Montesinos, PhD, MD22* and Bruno Paiva1*

1Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
2Hospital Universitario y Politécnico La Fe, Valencia, Spain
3Hospital San Pedro de Alcántara, Cáceres, Spain
4Hospital Germans Trias i Pujol, Badalona, ESP
5Hospital General de Albacete, Albacete, Spain
6Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
7Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
8Hospital Universitario Reina Sofía, IMIBIC, Cordoba, ESP
9Hospital Universitario Ramón y Cajal, Madrid, Spain
10Hospital Universitario de León, Leon, Spain
11Hospital Universitario Vall d'Hebrón, Barcelona, Spain
12Hospital Universitario Lucus Augusti, Lugo, Spain
13Hospital General Universitario de Alicante, Alicante, ESP
14Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
15Hospital Universitario de Salamanca, IBSAL, CIBER-ONC number CB16/12/00233 y Centro de Investigación, Salamanca, Spain
16Hospital Universitario de Burgos, Universidad Isabel I, Burgos, ESP
17Complejo Hospitalario Virgen del Rocío, Sevilla, ESP
18Hospital Dr. Peset, ZARAGOZA, ESP
19Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain
20Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain
21CIMA LAB Diagnostics, Universidad de Navarra, Pamplona, Spain
22Hospital Universitari i Politecnic la Fe, Valencia, Spain

Lok Lam Ngai, MD1,2*, Diana Hanekamp, PhD1,2*, Angèle Kelder1,2*, Willemijn Scholten1,2*, Jannemieke Carbaat-Ham1,2*, Mona M.H.E Fayed1,2*, Alexander N. Snel1,2*, Costa Bachas, PhD1,2*, Jesse M. Tettero, MD1,2*, Tim R. Mocking1,2*, Vincent H.J. Van Der Velden, PhD3*, Jennichjen Slomp, PhD4, Willemijn Hobo, PhD5*, Dimitri Breems, MD, PhD6, Thomas Fischer7, Bjorn T. Gjertsen, MD, PhD8, Laimonas Griškevičius, MD, PhD9*, Gunnar Juliusson, MD, PhD10, Johan Maertens, MD, PhD11*, Markus G. Manz, MD12,13, Thomas Pabst, MD13,14, Jakob Passweg Sr.13,15*, Kimmo Porkka, MD, PhD16, Peter J. M. Valk, PhD17, Patrycja Gradowska, PhD18,19*, Bob Löwenberg, MD, PhD17, David C. de Leeuw, MD, PhD1,2*, Arjan A. van de Loosdrecht, MD, PhD1,20, Gert Ossenkoppele, MD, PhD1,2 and Jacqueline Cloos, MD1,2*

1Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Erasmus MC, University Medical Center Rotterdam, Department of Immunology, Rotterdam, Netherlands
4Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, Netherlands
5Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands
6Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
7Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
8Haukeland University Hospital, Bergen, Norway
9Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
10Lund Stem Cell Center Lund University & Hospital, Lund, Sweden
11Department of Hematology, University Hospitals Leuven, Leuven, Belgium
12Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
13Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
14Institute of Medical Oncology, Berne, Switzerland
15University Hospital | Basel, Basel, Switzerland
16Helsinki University Central Hospital Cancer Center, Helsinki, FIN
17Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
18HOVON Data Center, Rotterdam, Netherlands
19Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
20Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands

Polina K Derevianko1*, Laura E. Swart, MSc1*, Minoo Ashtiani, BSc1*, Sophie Kellaway, PhD2*, Anja Krippner-Heidenreich, PhD1*, Raymond M. Schiffelers, PhD3,4*, Josef Vormoor, MD PhD1 and Olaf Heidenreich, PhD1,5

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Institute of Cancer & Genomic Science, University of Birmingham, Birmingham, United Kingdom
3Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands
4Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
5Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, United Kingdom

Mohammad Javad Najaf Panah, MS1*, Tsz-Kwong Man, PhD1*, Michael Krueger1*, Pavel Sumazin, PhD2* and Michele S. Redell, MD1

1Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
2Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX

Yazan Abu-Shihab, MD1*, Deedra Nicolet2,3, Krzysztof Mrózek, MD, PhD4, Mark Routbort, MD, PhD5*, Keyur P. Patel, MBBS, PhD6, Christopher J. Walker, PhD3*, Jill Buss, BS4, Andrew Stiff, MD, PhD7, Andrea Laganson, MS8*, Courtney D. DiNardo, MD, MSc9, Naval Daver, MD9, Tapan M. Kadia, MD9, Gautam Borthakur, MD9, Farhad Ravandi, MD, MBBS9, Andrew J Carroll, PhD10, Jonathan E Kolitz, MD11, Bayard L Powell, MD12, William Blum, MD13, Maria R. Baer, MD14, Guido Marcucci, MD15, Geoffrey L Uy, MD16, Wendy Stock, MD17, Richard M Stone, MD18, L. Jeffrey Medeiros, MD5, Robert L. Bowman, PhD19, John C. Byrd, MD20, James S. Blachly21, Linde A. Miles, PhD22,23, Ann-Kathrin Eisfeld, MD*3,24 and Sanam Loghavi, MD25,26

1The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH
3Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
4Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
5Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Depatment of Internal Medicine, Division of Hematology, Ohio State University, Columbus, OH
8Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
11Northwell Health, Lake Success, NY
12Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
13Winship Cancer Institute of Emory University, Atlanta, GA
14Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
15Hematology/HCT, City of Hope National Medical Center, Duarte, CA
16Division of Oncology, Washington University School of Medicine, Saint Louis, MO
17University of Chicago Medicine, Chicago, IL
18Dana-Farber Cancer Institute, Boston, MA
19Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
20Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
21Department of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
22Cincinnati Children's Hospital Medical Center, Cincinnati, OH
23Equal contribution, Cinicinnati, OH
24Contributed equally, #
25Hematopathology, MD Anderson Cancer Center, Houston, TX
26Equal contribution, Houston, TX

Xiaosu Zhou, PhD1*, Xue Chen, MD2*, Jiaqi Chen, PhD1,2*, Panxiang Cao, MS1,2*, Fang Wang, MD2*, Yang Zhang, MD1,2*, Xiaoli Ma, MD2*, Jiancheng Fang2*, Linya Wang, MD3*, Lijun Wen, MD4*, Ping Wu, MD2*, Ruijie Tang, MD5*, Wanting He, MD6*, Siyuan Liu1*, David Jin, MD1*, Xian Zhang, MD5*, Suning Chen, MD4*, Huyong Zheng, MD, PhD3, Peihua Lu, MD5* and Hongxing Liu1,2,7,8

1Molecular Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China
2Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
3Hematology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
4National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
5Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China
6Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
7Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China
8Department of Oncology, Capital Medical University, Beijing, China

Sun Loo, MBBS1,2, Nicola Potter, PhD3*, Adam Ivey, PhD4,5*, Jenny O'Nions, MBBCh, PhD, MRCP, FRCPath6*, Roderick Moon5*, Chun Yew Fong, MBBS, FRACP, FRCPA, PhD7, Natasha Anstee8*, Ing Soo Tiong, FRACP, FRCPA, MPhil4,9, Chong Chyn Chua, MBBS, FRACP, FRCPA, PhD2,4, Jad Othman, MBBS3,10,11, Hannah Renshaw6*, Robert Baker12*, Nigel H. Russell, MD10, Ashish Bajel, FRACP1, Hsin-An Hou, MD, PhD13, Richard Dillon, PhD, MRCP, FRCPath3,10* and Andrew H. Wei, MBBS, PhD14,15

1Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
2The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
3Department of Medical and Molecular Genetics, King's College London, London, United Kingdom
4The Alfred Hospital and Monash University, Melbourne, VIC, Australia
5Human Molecular Pathology, The Alfred Hospital, Melbourne, Australia
6Department of Hematology, University College London NHS Foundation Trust, London, United Kingdom
7Austin Hospital, Heidelberg, Australia
8The Walter and Eliza Hall Institute of Medical Research, Parkville, AUS
9Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
10Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
11Royal North Shore Hospital, London, United Kingdom
12Health Service Laboratories, UCLH, London, United Kingdom
13Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
14Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
15The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Yutong Zhou1*, Yu Qian1* and Jie Jin2

1Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;, Hangzhou, China

Somadri Ghosh1*, Maria Rodriguez Zabala, BSc, MSc2*, Gladys Telliam Dushime, PhD3*, Katrin Reinbach4*, Ramprasad Ramakrishnan, PhD5*, Ewa Sitnicka, PhD6* and Marcus Järås, PhD4*

1Division of Clinical Genetics, Lund University, Lund, Sweden
2Clinical Genetics, Lund Universitet, Lund, Sweden
3Division of Molecular Hematology, Lund University, Lund, Skane, Sweden
4Division of Clinical Genetics, Lund University, Lund, Skåne, Sweden
5Lund University, Lund, Skåne, SWE
6Division of Molecular Hematology, Lund University, Lund, Sweden

Maddalena Benetton, PhD1*, Pietro Merli, MD2*, Nicola Santoro, MD3*, Luca Lo Nigro, MD4, Claudia Tregnago, PhD1*, Ambra Da Ros, PhD1*, Katia Polato1*, Veronica Zampieri, BS5*, Barbara Michielotto, BS1*, Samuela Francescato, MSc5*, Anna Leszl, MSc5*, Riccardo Masetti, MD, PhD6*, Barbara Buldini, MD, PhD7, Alessandra Biffi, MD, PhD1*, Franca Fagioli, MD8*, Carmelo Rizzari, MD9*, Franco Locatelli, MD, PhD10 and Martina Pigazzi, PhD1,11*

1Department of Women's and Children's Health, Onco-hematology lab and clinic, University of Padova, Padova, Italy
2Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children’s Hospital, Catholic University of the Sacred Heart, Rome, Italy
3Department of Pediatric Hemato-Oncology, University of Bari, Bari, Italy
4Azienda Policlinico OVE - Center of Pediatric Hematology Oncology, Catania, Italy, Italy
5Pediatric Onco-hematology Unit, Azienda Ospedaliera di Padova, Padova, Italy
6Department of Pediatrics, "Lalla Seràgnoli", Hematology-Oncology Unit, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
7Department of Pediatric Hematology and Oncology, University of Padova, Padua, Italy
8Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
9Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation c/o ASST Monza, Milan, Italy
10IRCCS Bambino Gesù Children’s Hospital, Catholic University of the Sacred Heart, Rome, Italy
11Foundation Istituto Ricerca Pediatrica (IRP), Padova, Italy

Eduardo Sabino de Camargo Magalhaes, MD1*, Stefan Hubner2*, Brandon D. Brown, MD3*, Yihua Qiu4* and Steven M. Kornblau, MD4

1Department of Ageing Biology/ERIBA, University Medical Center Groningen, Groningen, Netherlands
2John Sealy School of Medicine, The University of Texas Medical Branch (UTMB), Galveston, TX
3Department of Pediatrics, MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Daniel Lopes De Menezes, PhD1*, Manuel Ugidos Guerrero, PhD2*, Arnaud Amzallag, PhD3*, Wendy L. See, PhD4*, Alberto Risueno, PhD5*, Charalampos Kyriakopoulos, PhD3*, Rajasekhar N.V.S. Suragani, PhD6, Barry S. Skikne, MD7*, C.L. Beach, PharmD8*, Thomas Prebet, MD, PhD9*, Maria Teresa Voso, MD10, Andre C. Schuh, MD, FRCPC11, Gail J. Roboz, MD12, Hartmut Döhner, MD13, Andrew H. Wei, MBBS, PhD14 and Anita K. Gandhi, PhD15

1Translational Medicine, Hematology, Bristol Myers Squibb, San Francisco, CA
2BMS Center for Innovation and Translational Research Europe (CITRE, a Bristol Myers Squibb Company), Bristol Myers Squibb, Seville, Spain
3Bristol Myers Squibb, Princeton, NJ
4Hematology, Translational Medicine, Bristol Myers Squibb, San Francisco, CA
5Bristol Myers Squibb, Lawrenceville, NJ
6Hematology, Translational Medicine and Disease Team, Bristol Myers Squibb, Summit, NJ
7Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
8Bristol Myers Squibb (former affiliation), Summit, NJ
9Bristol Myers Squibb, Summit, NJ
10Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
11Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
12Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
13Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
14Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
15Translational Development and Diagnostics, Bristol Myers Squibb, Summit, NJ

Fumiya Wada, MD1,2*, Shoya Kato1*, Shruti Bhagat1*, Shigeki Hirabayashi, MD, PhD3*, Raku Son4*, Akiko Oguchi4*, Kazuhiro Takeuchi1*, Sho Sekito1*, Tomoya Hirai4*, Zhiwei Zhang1,5*, Yoshihito Horisawa2*, Makoto Iwasaki, MD, PhD6*, June Takeda, MD2*, Junya Kanda2, Takashi Sakamoto2*, Kotaro Shirakawa, MD, PhD2, Akifumi Takaori-Kondo, MD, PhD2 and Yasuhiro Murakawa1,4,7*

1ASHBi Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan
2Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
4RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
5Department of Human Genetics, Faculty of Medicine and Health Science, McGill University, Montreal, Canada
6Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Nara, NAR, Japan
7IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy

Jessica Lynn Root, MS Biomedical Informatics1*, Poonam N Desai2, Patrick K Reville, MD, MPH2, Christopher Ly1*, Bofei Wang, Ph.D.2*, Fatima Z Jelloul3*, Jing Zhou4*, Sean Gregory Mackay4*, Mansour Alfayez, MD, MS5, Jairo Matthews, BA6*, Sherry Pierce, BSN, BA2*, Naval Daver, MD2 and Hussein A Abbas, MD, PhD2

1Department of Leukemia, The University of Texas at MD Anderson Cancer center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4IsoPlexis Corporation, Branford, CT
5Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Saudi Arabia
6The University of Texas at MD Anderson Cancer center, Houston, TX

Nika Panahi1*, Tiffany Hylkema, BS2*, Grace Hawkins1*, Makia K Manselle1*, Jack H Peplinski, BS2*, Logan K Wallace1*, Rhonda E Ries, MA2*, Soheil Meshinchi, MD, PhD3 and Danielle C Kirkey, MD1,4

1Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
2Translational Sciences and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
3Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA
4Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA

Dominique Sternadt1*, Diego Pereira-Martins, PhD2,3*, Douglas RA Silveira, MD, PhD4*, Isabel Weinhaeuser, PhD1,2*, Ming Yang, PhD5*, Prodromos Chatzikyriakou2*, Pilar Casares Alaez6*, Emanuele Ammatuna, MD, PhD1*, Lieve Oudejans, MSc3*, Gerwin A. Huls, PhD3, Christian Frezza, PhD5*, Lynn Quek, MD, PhD2* and Jan Jacob Schuringa, PhD7

1Department of Experimental Hematology, University Medical Centre Groningen, Groningen, Netherlands
2Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
3Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
4School of Cancer and Pharmaceutical Sciences, King's College London, London, ENG, United Kingdom
5University of Cologne, Cologne Excellence Cluster on Stress Responses in Ageing-Associated Diseases, Cologne, Germany
6Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King’s College London, London, United Kingdom
7Department of Experimental Hematology, University Medical Center - Groningen, Groningen, Netherlands

Paula Rothämel1*, Semjon Willier, MD2*, Jonas Wilhelm1*, Fiona AG Becker-Dettling1*, Theresa Kaeuferle1*, Franziska Blaeschke1, Meino Rohlfs1*, Irene Schmid1*, Vera Binder1*, Christoph Klein1,3, Thomas Walzthoeni4,5*, Matthias Heinig5,6,7* and Tobias Feuchtinger, MD2,8,9

1Department of Pediatrics, Dr. von Hauner Children’s Hospital, LMU University Hospital, LMU Munich, Munich, Germany
2Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Munich, Germany
3Gene Center, LMU Munich, Munich, Germany
4Core Facility Genomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany
5Institute of Computational Biology (ICB), Helmholtz Center Munich, German Research Center for Environmental Health, Oberschleißheim, Germany
6Department of Computer Science, TUM School of Computation, Information and Technology, Technical University of Munich, Garching, Germany
7German Centre for Cardiovascular Research (DZHK), Munich Heart Association, Partner Site Munich, Berlin, Germany
8German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany
9German Center for Infection Research (DZIF), Munich, Germany

Evgeny Klyuchnikov1*, Anita Badbaran2*, Radwan Massoud, BS, MD3*, Petra Freiberger4*, Christine Wolschke5*, Francis A. Ayuk, MD6*, Ulrike Bacher7* and Nicolaus Kroeger, MD5

1Department of Stem Cell Transplantation,, University Medical Center Hamburg Eppendorf, Hamburg, DEU
2Department of stem cell transplantation, University Hospital Hamburg Eppendorf, Hamburg, DEU
3Department of Stem Cell Transplantation, University Medical Center Hamburg Eppendorf, Hamburg, Germany
4Department for Stem Cell Transplantation, University Cancer Center Hamburg-Eppendorf, Hamburg, Germany
5Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6University Hospital Hamburg, Hamburg, Germany
7Department of Hematology and Central Hematology Laboratory, Bern, CHE

Jan Philipp Bewersdorf, MD1, Shai Shimony, MD2*, Rory M. Shallis, MD3, Yiwen Liu, MS4*, Eva Johanna Schaefer, MD5*, Amer M. Zeidan, MBBS, MHS6, Aaron D. Goldberg, MD, PhD7, Eytan M. Stein1, Guido Marcucci, MD8, R. Coleman Lindsley9, Evan C. Chen, MD5, Jorge Ramos, MD10*, Anthony Selwyn Stein, MD11, Daniel J. DeAngelo12, Donna S. Neuberg, ScD4, Richard M Stone, MD12, Brian J. Ball, MD10 and Maximilian Stahl, MD13

1Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Section of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT
4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
5Medical Oncology, Dana Farber Cancer Institute, Boston, MA
6Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
7Memorial Sloan Kettering Cancer Center, New York City, NY
8Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
9Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
10City of Hope Cancer Center, Duarte, CA
11City of Hope National Medical Center, Duarte, CA
12Dana-Farber Cancer Institute, Boston, MA
13Dana Farber Institute, Boston, MA

Barbara Buldini, MD, PhD1, Pietro Merli, MD2*, Elena Varotto, MD, PhD3*, Riccardo Masetti, MD4*, Maria Gabelli, MD, PhD5*, Marco Zecca, MD6*, Franca Fagioli, MD7*, Pamela Scarparo, PhD8*, Mattia Algeri, MD2*, Alessandra Biffi, MD, PhD9*, Martina Pigazzi, PhD10*, Daria Pagliara, MD, PhD2* and Franco Locatelli, MD, PhD11

1Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Università degli Studi di Padova, Padova, Italy
2Department of Haematology-Oncology and Cell and Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy
3Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, University of Padova, Padova, Italy, University of Padua, Padova, Italy
4Pediatric Oncology and Hematology Unit "lalla Seràgnoli," Department of P, Bologna, ITA
5Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department,, University of Padova, Padova, Italy
6Pediatric Hematology-Oncology,, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
8Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, University of Padova, Padova, Italy
9Padua University Hospital, Pediatric Hematology, Oncology and Stem Cell Transplant Division, Padova, Italy
10Department of Women's and Children's Health, Onco-hematology lab and clinic, University of Padova, Padova, Italy
11Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Bambino Gesù Children's Hospital, Catholic University of the Sacred Heart, Roma, Italy

Maria Sirenko, PhD1,2,3,4,5, Soobeom Lee2,4,5,6*, Zhengxi Sun2,4,5*, Ronan Chaligne, PhD7*, Georgios Asimomitis3,8*, Charlotte K Brierley, bmbch9, Elsa Bernard, PhD3*, Sheng F. Cai, MD, PhD10*, Robert M Myers, PhD11, Bettina Nadorp, PhD4,12*, Max F Levine3*, Dylan Domenico3*, Juan E Arango Ossa3*, Juan Santiago Medina Martinez3*, Kamal Menghrajani, MD10, Audrey Lasry, PhD4*, Alice Mims, MD13,14, Helee Desai13,14*, Andrea Laganson, MS13,14*, Christopher Famulare, MS15*, Minal Patel, BA15*, Gerard Lozanski, MD16*, Sanam Loghavi, MD17, Kelly L. Bolton, MD10,18, Aaron D. Viny, MD, MS19,20, Mikhail Roshal, MD, PhD21*, Ross L Levine, MD22, Eytan M. Stein10, Dan A. Landau, MD, PhD23,24,25,26*, Ann-Kathrin Eisfeld, MD*14,26,27,28, Iannis Aifantis, PhD4,26,29 and Elli Papaemmanuil, PhD3,26

1Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY
2Contributed equally, *
3Computational Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pathology, NYU Grossman School of Medicine, New York, NY
5Laura & Isaac Perlmutter Cancer Center, NYU Langone, New York, NY
6Department of Biology, New York University, New York
7Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
8Biomedical Systems Laboratory, Department of Mechanical Engineering, National Technical University of Athens, Athens, Greece
9Medical Research Council (MRC) Weatherall Institute of Molecular Medicine (WIMM) and NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
10Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
11Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY
12Division of Precision Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, NY
13Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
14Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
15Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
16Department of Pathology, The Ohio State University, Columbus, OH
17Hematopathology, MD Anderson Cancer Center, Houston, TX
18Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, Saint Louis, MO, Washington University In St Louis, St Louis, MO
19Leukemia Service, Department of Medicine, Center for Hematologic Malignancies,, Memorial Sloan Kettering Cancer Center, New York, NY
20Columbia Stem Cell Initiative, Columbia University, New York, NY
21Memorial Sloan Kettering Cancer Center, New York
22Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
23New York Genome Center, New York
24Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York
25Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York
26Corresponding author, #
27Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
28Pelotonia Institute for Immuno-Oncology, OSUCCC – James, The Ohio State University, Columbus, OH
29New York University, Grossman School of Medicine, New York, NY

Hui Zeng, MD, PhD1, Suqi Deng2*, Juan Du2*, Huien Zhan2*, Kexiu Huang1*, Xue Zheng2*, Ying Xu1* and Lu Wang3*

1The First Affiliated Hospital of Jinan University, Guangzhou, China
2The First Affiliated Hospital of Jinan University, Guangzhou, CHN
3Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, China

Andy G.X. Zeng1,2, Ilaria Iacobucci, PhD3, Sayyam Shah1*, Gordon Wong, BS1,2*, Amanda Mitchell, PhD1*, Qingsong Gao, PhD3*, Hyerin Kim1*, Mark D. Minden1,4*, Torsten Haferlach, MD, PhD5, Charles G. Mullighan, MBBS, MD3 and John E. Dick, PhD1,2

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
3Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
4Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
5MLL Munich Leukemia Laboratory, Munich, Germany

Andrea B Moffitt, PhD1, Joan Alexander, MD2*, Asya Stepansky2*, Erin Boyle, MS3*, Danielle Stauder2*, Carlos Alberto Lopez, MD, MPH4, Vernon Wu, MD5*, Nausheen Hakim, MD6*, Zihua Wang, PhD2*, Jonathan E Kolitz, MD7,8, Nicholas Chiorazzi, MD9, David W Chitty, DO, MSc10, Steven L. Allen, MD8,11, Dan Levy, PhD2* and Michael Wigler2*

1Winship Cancer Institute, Emory University, Atlanta, GA
2Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
3Feinstein Institutes for Medical Research, Northwell Health, Manhassett, NY
4Emory University, Atlanta, GA
5Northwell Health, New Hyde Park, NY
6Northwell Health, Manhasset, NY
7Zucker School of Medicine at Hofstra/Northwell, Zuckerberg Cancer Center, Lake Success, NY
8Department of Medicine, Northwell Health, Manhasset, NY
9Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Manhasset, NY
10Zuckerberg Cancer Center, Northwell Health, New Hyde Park, NY
11Monter Cancer Center, North Shore University Hospital, Lake Success, NY

Josephine Anne Lucero, MD1,2, Aniket Bankar, MD, MBBS, MSc, DM1,2, Marta Beata Davidson, MD, PhD1, Guillaume Richard-Carpentier, MD, FRCPC1, Aaron D. Schimmer, MD3, Andre C. Schuh, MD, FRCPC2,4, Dawn C. Maze, MD, FRCPC, MSc1, Karen Yee, MD, FRCPC1*, Mark D. Minden1*, Steven M. Chan, MD, PhD1,2, Jonas Mattsson, MD, PhD1,2*, Rajat Kumar, MD, FRCPC1,2, Vikas Gupta, MD1,2, Jose-Mario Capo-Chichi, PhD2,5*, Tracy Stockley, PhD2,6*, Hassan Sibai, MD1, Anne Maria Tierens, MD, PhD2,7 and Dennis Dong Hwan Kim, MD, PhD1,2

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Measurable Residual Disease Working Group, Princess Margaret Cancer Centre, Toronto, ON, Canada
3Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
4Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
6Division of Clinical Laboratory Genetics and Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
7Division of Hematology and Transfusion Medicine, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada

Livius Penter, MD1,2,3,4, Mehdi Borji, MS2,3,5*, Adi Nagler, PhD2*, Haoxiang Lyu, BS5*, Wesley S Lu, BS5*, Nicoletta Cieri, MD, PhD2,3,4, Alexandria Maurer, MD, PhD2,3,4, Giacomo Oliveira, PhD2,3,4*, Aziz M. Al'Khafaji, PhD6*, Kiran Garimella, DPhil7*, Shuqiang Li, PhD3,5*, Donna S. Neuberg, ScD8, Jerome Ritz, MD2,4, Robert J. Soiffer, MD2,4, Jacqueline S. Garcia, MD4,9, Kenneth J. Livak, PhD2,5* and Catherine J Wu, MD2,3,4

1Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Harvard Medical School, Boston, MA
5Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
6Methods Development Lab, Broad Institute of MIT and Harvard, Cambridge, MA
7Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA
8Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Ravindu De Silva1,2*, Matthew Markham, PhD2*, Rebecca S Maynard, MSc3*, Katherine Hampton, MSc, BSc2*, Charlotte Hellmich, PhD, BSc, MBBChir1,2, Dominic Fowler-Shorten3*, Kristian Bowles, MBBS, PhD1,2 and Stuart Rushworth, PhD2

1Norfolk and Norwich University Hospital, Norwich, United Kingdom
2Norwich Medical School, University of East Anglia, Norwich, United Kingdom
3Norwich Medical School, University of East Anglia, Norwich, ENG, United Kingdom

Dorian Forte1*, Filippo Maltoni, PhD Student1*, Samantha Bruno, PhD1*, Paulina Garcia-Gonzalez, PhD2*, Gianluca Cristiano, MD1*, Chiara Sartor, MD1*, Simona Soverini, PhD3, Lucia Catani, PhD1,4*, Rafael José Argüello, PhD2*, Michele Cavo, MD1,4* and Antonio Curti, MD, PhD5

1Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy
2Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France
3Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Castel Maggiore, Bologna, Italy
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
5Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy

Shin-Ichi Tsujimoto, MD, PhD1*, Shota Kato, MD2*, Shotaro Iwamoto, MD, PhD3*, Hidefumi Hiramatsu, MD, PhD4, Yusuke Okuno, MD, PhD5*, Tatsuya Kamitori, MD6*, Kentaro Ohki, MD, PhD7*, Takao Deguchi, MD, PhD8, Nobutaka Kiyokawa, MD, PhD9*, Motohiro Kato, MD10, Junko Takita, MD, PhD11*, Souichi Adachi, MD, PhD12*, Daisuke Tomizawa, MD, PhD13 and Norio Shiba, MD, PhD14

1Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
2Department of Pediatrics, The University of Tokyo, Tokyo, JPN
3Department of pediatrics, Mie University Graduate School of Medicine, Tsu, JPN
4Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
6Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, Japan
7Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan
8Division of Cancer Immunodiagnostics, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, JPN
9Department of Pediatric Hematology and Oncology Research, National Research Institute For Child Health and Development, Tokyo, JPN
10Department of Pediatrics, The University of Tokyo, Tokyo, Japan
11Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, JPN
12Human Health Science, Graduate School of Medicine Kyoto University, Kyoto, JPN
13Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
14Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, JPN

*signifies non-member of ASH